关于结核病和潜在结核病感染治疗的最新情况
Henry M Blumberg1, Michael K Leonard, Robert M Jasmer
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Ga 30303, USA. henry.m.blumberg@emory.edu
JAMA
|June 9, 2005
概括
结核病 (TB) 是一个全球性的健康问题. 治疗包括6-9个月的4种药物治疗方案,建议直接观察治疗以改善结果并预防耐药性.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 结核病 (TB) 仍然是一个重要的全球公共卫生问题,特别是在城市地区和美国的特定患者群体.
- 虽然自1992年以来结核病例已经下降,但持续存在的挑战需要强有力的控制策略.
- 结核病治疗完成的管理和预防耐药性是关键的公共卫生责任.
研究的目的:
- 概述当前的结核病治疗指南,并强调其遵守的重要性.
- 突出直接观察治疗 (DOT) 在改善治疗完成和预防耐药性的作用.
- 讨论重新关注潜伏性结核病感染 (LTBI) 治疗作为关键的结核病消除战略.
主要方法:
- 针对活跃结核病的标准多种药物治疗方案,通常是异化,利法,皮拉津胺和乙墨托.
- 直接观察治疗 (DOT) 是所有被诊断为结核病患者的推干预措施.
- 潜在结核病感染 (LTBI) 的查和治疗方案,重点关注高风险人群.
主要成果:
- 对药物敏感结核病的基于里法的治疗方案需要至少6到9个月的治疗.
- DOT与更高的治疗完成率和药物耐药结核病风险降低有关.
- 9个月的伊索尼亚是治疗潜伏结核病感染的首选方案.
结论:
- 有效的结核病控制需要遵守规定的治疗方案和策略,如DOT.
- 针对潜伏结核病感染的向治疗对于消除结核病储存库至关重要.
- 开发新型抗结核病药物的持续,迫切需要.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
相关概念视频
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...